Medicine & Life Sciences
Neoplasms
100%
Breast Neoplasms
98%
Colorectal Neoplasms
45%
Biomarkers
32%
Adenocarcinoma
30%
Pancreatic Neoplasms
28%
Breast
27%
Chemoprevention
27%
Hereditary Nonpolyposis Colorectal Neoplasms
26%
Retinoic Acid Receptors
25%
Neoplasm Metastasis
25%
Genes
25%
Carcinogenesis
25%
Early Detection of Cancer
24%
Proteins
22%
Estrogen Receptors
22%
Therapeutics
22%
Triple Negative Breast Neoplasms
21%
Apoptosis
21%
Growth
21%
Lung Neoplasms
21%
Survival
20%
Retinoids
20%
Adenocarcinoma of Lung
19%
Mutation
19%
Prostatic Neoplasms
18%
Tamoxifen
17%
Confidence Intervals
16%
Esophageal Neoplasms
15%
Carcinoma, Intraductal, Noninfiltrating
15%
Cell Line
15%
Cancer Survivors
15%
Arachidonate 15-Lipoxygenase
15%
Non-Small Cell Lung Carcinoma
14%
DNA Damage
14%
DNA Mismatch Repair
14%
Proteomics
14%
Colonic Neoplasms
13%
Lipoxygenase
13%
Esophageal Squamous Cell Carcinoma
12%
Gene Expression
12%
Ovarian Neoplasms
12%
Epithelial Cells
11%
Drug Therapy
11%
MicroRNAs
11%
Tumor Microenvironment
11%
Adenoma
11%
Risk Reduction Behavior
11%
Phenotype
10%
Raloxifene Hydrochloride
10%
Clinical Trials
10%
Pharmaceutical Preparations
10%
Recurrence
10%
DNA Repair
10%
Messenger RNA
10%
Epithelial-Mesenchymal Transition
10%
Squamous Cell Carcinoma of Head and Neck
10%
Bexarotene
9%
In Vitro Techniques
9%
Up-Regulation
9%
Exercise
9%
Neoplastic Stem Cells
9%
Genome
9%
Lung
9%
Placebos
8%
Adenomatous Polyposis Coli
8%
Retinoid X Receptors
8%
Population
8%
Celecoxib
8%
Rectal Neoplasms
8%
Serum
8%
Prophylactic Mastectomy
8%
Cell Movement
8%
Phosphotransferases
7%
Immunotherapy
7%
Metabolomics
7%
Mortality
7%
Risk Assessment
7%
Microsatellite Instability
7%
Poly(ADP-ribose) Polymerase Inhibitors
7%
Odds Ratio
7%
DNA
7%
Transcription Factor AP-1
7%
Squamous Cell Carcinoma
7%
Heterografts
7%
Down-Regulation
7%
ErbB Receptors
7%
gemcitabine
7%
Estrogens
6%
Hormones
6%
Anti-Inflammatory Agents
6%
European Continental Ancestry Group
6%
Turcot syndrome
6%
Recombinational DNA Repair
6%
oridonin
6%
Obesity
6%
Inflammation
6%
Autoantibodies
6%
Long Noncoding RNA
6%
Cyclooxygenase 2
6%